In renal cancer, lncARSR functions as miRNA sponge to competitively bind with miR-34 and miR-449, which can up-regulate AXL/c-MET and activate STAT3, AKT, and ERK signaling 18. The gene discussed is MET; the disease is renal carcinoma.